Please assess the completion status of the following clinical trial:

Trial Title: Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must have histologically confirmed squamous cell, adenosquamous or adenocarcinoma of the cervix~* Subjects must have non-metastatic FIGO Stage Ia-IVa cervical cancer~* Claustrophobic subjects must agree to be sedated during MRI procedures~* ECOG performance status of 0-2~Exclusion Criteria:~* Subjects with an inability to tolerate MR imaging~* Subjects who have had prior surgery for treatment of disease other than exploratory laparotomy or biopsy~* Study subjects who have contraindication to MRI scanning such as but not limited to subjects with pacemakers, metal fragments in the eye or certain metallic implants~* Women of childbearing potential who have a positive result on screening serum pregnancy test

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm I (Type: EXPERIMENTAL): Patients undergo external beam radiotherapy (3-dimensional conformal OR intensity-modulated) and 4-6 insertions of MRI-guided intracavitary brachytherapy over 8 weeks. Patients also receive cisplatin IV over 30-60 minutes for 5-6 weeks during radiotherapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).